| 000 | 01233 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516172909.0 | ||
| 264 | 0 | _c20140506 | |
| 008 | 201405s 0 0 eng d | ||
| 022 | _a1744-8042 | ||
| 024 | 7 |
_a10.2217/pgs.13.137 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLymperopoulos, Anastasios | |
| 245 | 0 | 0 |
_aβ1- and α2C-adrenergic receptor polymorphisms and the antiarrhythmic effect of bucindolol in heart failure with reduced ejection fraction. _h[electronic resource] |
| 260 |
_bPharmacogenomics _cOct 2013 |
||
| 300 |
_a1545-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdrenergic alpha-1 Receptor Antagonists _xtherapeutic use |
| 650 | 0 | 4 |
_aAnti-Arrhythmia Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPolymorphism, Genetic _xgenetics |
| 650 | 0 | 4 |
_aPropanolamines _xtherapeutic use |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, alpha-2 _xgenetics |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, beta-1 _xgenetics |
| 700 | 1 | _aNegussie, Shmuel | |
| 700 | 1 | _aWalklett, Karlee | |
| 773 | 0 |
_tPharmacogenomics _gvol. 14 _gno. 13 _gp. 1545-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2217/pgs.13.137 _zAvailable from publisher's website |
| 999 |
_c23136397 _d23136397 |
||